Actively Recruiting
Using Mukbang to Improve Appetite, Nutritional Status and Quality of Life in Children With Cancer
Led by Wei XIA, PhD · Updated on 2025-08-06
124
Participants Needed
1
Research Sites
76 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to use a two arms randomized clinical trial study to evaluate the effectiveness of the effective constituent of Mukbang in helping children with cancer hospitalized for radiotherapy and chemotherapy to improve their appetite, nutritional status and quality of life.
CONDITIONS
Official Title
Using Mukbang to Improve Appetite, Nutritional Status and Quality of Life in Children With Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged between 6 to 18 years old
- Diagnosed with cancer according to the 2021 guidelines for hematologic diseases and malignant tumors
- Completed at least one full cycle of chemotherapy
- Has moderate or higher symptoms of decreased appetite based on treatment-related symptom screening
You will not qualify if you...
- Has serious cardiopulmonary disease, infection, organ damage, genetic metabolic disease, immune deficiency disease, or mental illness
- Has eye or ear dysfunction preventing watching and listening to videos
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sun Yat-sen Memorial Hospital
Guangzhou, Guangdong, China, 510080
Actively Recruiting
Research Team
W
Wei Xia, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here